KMX
38
-9
C
84
2
VTR
69
2
PEP
32
-3
MOS
32
3
LEN
21
-9
RSG
45
-2
IP
34
6
ROP
42
4
NI
67
2
TROW
62
6
OXY
42
2
PGR
44
2
UA
36
3
OI
58
11
MS
76
2
PVH
30
-2
EOG
37
4
DLTR
58
-5
DHI
37
-3
KMX
38
-9
C
84
2
VTR
69
2
PEP
32
-3
MOS
32
3
LEN
21
-9
RSG
45
-2
IP
34
6
ROP
42
4
NI
67
2
TROW
62
6
OXY
42
2
PGR
44
2
UA
36
3
OI
58
11
MS
76
2
PVH
30
-2
EOG
37
4
DLTR
58
-5
DHI
37
-3
Financhill
Back

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
42

VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF

Last Price:
$83.53
Seasonality Move:
-0.9%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Sell
42
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT) is a Sell

Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $83.62. The Score for VCIT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • VCIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCIT Stock Price Chart

What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?

  • The Vanguard Intermediate-Term Corp Bond Idx Fund ETF share price today is $83.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

VCIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 18.62 Buy
Relative Strength Index (14 RSI): 42.16 Sell
Chaikin Money Flow: 7460143 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.66 - 84.22) Sell
Bollinger Bands (100): (83.34 - 84.36) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

VCIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.79 Sell
20-day SMA: 83.99 Sell
50-day SMA: 84.06 Sell
200-day SMA: 82.67 Buy
8-day EMA: 53.07 Buy
20-day EMA: 27.62 Buy
50-day EMA: 12.38 Buy
200-day EMA: 3.28 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):